Although PI3K and Akt enhances Bcl-2 promoter activity by phosphorylating NFκB, which is elevated in NMO patients, PI3K and Akt showed no significant increase in NMO patients (P > 0.05) (Figures 4A,B). Here, AKT1 is linked to neuromyelitis optica.